CN Stock MarketDetailed Quotes

Zhejiang Huakang Pharmaceutical (605077)

Watchlist
  • 18.58
  • -0.29-1.54%
Trading May 14 13:39 CST
5.63BMarket Cap39.79P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Huakang Pharmaceutical (605077) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
液体糖、醇及其他产品2.06B49.26%
晶体糖醇产品1.98B47.34%
Other112.46M2.68%
Other business29.98M0.72%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Food manufacture4.16B99.28%
Other business29.98M0.72%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Territory2.8B66.92%
Overseas1.36B32.36%
Other business29.98M0.72%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +4.61%
Sample Name
Sample Code
 +3.31%
Sample Name
Sample Code
 +2.36%
4
CNOOC
00883
+1.14%
5
SINOPEC CORP
00386
+0.88%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +47.30%
Sample Name
Sample Code
 +40.76%
Sample Name
Sample Code
 +31.92%
4
Loongson Technology Corporation
688047
+22.60%
5
Digital China Group
000034
+16.81%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -